trending Market Intelligence /marketintelligence/en/news-insights/trending/8cr9tygt2o4fs4qyd15sxg2 content esgSubNav
In This List

Mayne Pharma adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mayne Pharma adds board member

Australian drug manufacturer Mayne Pharma Group Ltd. appointed Frank Condella to its board.

Condella is vice chairman of Vectura Group PLC and a board member of privately held biotechnology company Palladio Biosciences Inc., according to his LinkedIn profile.